National News Partner

EpiPen Maker Mylan Finalizes Its $465M Settlement With The Feds

Mylan will pay $465 million to the federal government in a settlement over one of its EpiPen scandals.

Mylan made headlines over the past year after hiking the price of its life-saving EpiPens from $100 to more than $600 for a two-pack — but that's not what it's answering for right now.

In October, Mylan was accused of shortchanging the government by knowingly misclassifying its brand name EpiPen as a generic drug. That allowed it to pay less in rebates to Medicaid.

SEE MORE: A Lot Of EpiPens Are Being Recalled Because Of A Potential Defect

Some say the finalized $465 million settlement isn't enough. The government estimates Mylan overcharged Medicaid $1.27 billion over 10 years. Sen. Chuck Grassley said: "The settlement is a disappointment."

The settlement allows Mylan to avoid admitting any wrongdoing.

Trending stories at

Watch Newsy Everywhere

Mobile Apps

See All Apps
download newsy apple download newsy android

Streaming TV Devices

See All Devices
stream newsy roku stream newsy amazon stream newsy apple tv